Technology
Health
Medical
OncoCyte
$3.529876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$3.52
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.17 (-4.61%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell OncoCyte and other stocks, options, ETFs, and crypto commission-free!
About
OncoCyte Corporation, also called OncoCyte, is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. Read More The company was founded in September 2009 and is headquartered in Alameda, CA.
Employees
16
Headquarters
Alameda, California
Founded
2009
Market Cap
150.05M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
373.47K
High Today
$3.80
Low Today
$3.46
Open Price
$3.73
Volume
113.30K
52 Week High
$6.92
52 Week Low
$1.17
Collections
Technology
Health
Medical
Pharmaceutical
Cancer Prevention
2015 IPO
US
North America
News
Markets Insider6h
OncoCyte to Report Fourth Quarter and Full-Year 2018 Financial Results on Monday, April 1, 2019
ALAMEDA, Calif., March 25, 2019 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the early detection of cancer, announced today that it will release its financial and operating results for the fourth quarter and year ended December 31, 2018, on Monday, April 1, 2019, after the close of the U.S. financial markets. The Company will host a conference call on Monday, April 1, 2019, at 4:30 pm ET / 1:30 pm PT to discuss the results along with recent corp...
Price Paid on Robinhood
18% Lower
Right Now
52 Week Low
$1.17
Average Price Paid
$4.29
52 Week High
$6.92
Earnings
-$0.22
-$0.17
-$0.12
-$0.07
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
—
Actual
Expected Mar 27, After Hours